Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Daiichi-Sankyo
Company Monitoring Page for Daiichi-Sankyo
latest headlines for company on cafepharma
FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers
Investing.com
Sun, 04/7/24 - 04:45 pm
Tags:
AstraZeneca
,
Daiichi Sankyo
,
FDA
,
Enhertu
,
solid tumors
Daiichi Sankyo and Merck dose first subject in ovarian cancer trial
Clinical Trials Arena
Thu, 04/4/24 - 10:53 am
Tags:
Daiichi Sankyo
,
Merck
,
ovarian cancer
,
clinical trials
,
raludotatug deruxtecan
,
R-DXd
AZ, Daiichi Sankyo file Dato-DXd for second indication
Pharmaphorum
Tue, 04/2/24 - 11:31 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
Dato-DXd
,
breast cancer
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
HER2-low breast cancer
,
Enhertu
,
NICE
,
UK
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
Tags:
oncology
,
clinical trials
,
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
metastatic breast cancer
,
Gilead Sciences
,
Trodelvy
,
bladder cancer
,
GSK
,
Zejula
,
Jemperli
,
ovarian cancer
,
Roche
,
tiragolumab
,
Tecentriq
,
non-small cell lung cancer
,
Cue Biopharma
,
CUE-101
,
head and neck cancer
,
Elicio Therapeutics
,
ELI-002
,
solid tumors
Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review
Clinical Trials Arena
Tue, 02/20/24 - 11:30 am
Tags:
Daiichi Sankyo
,
AstraZeneca
,
FDA
,
Tagrisso
,
non-small cell lung cancer
Daiichi invests 1 bln eur near Munich to make precision cancer drugs
Reuters
Fri, 02/16/24 - 11:51 am
Tags:
Daiichi Sankyo
,
precision medicine
,
cancer
,
Germany
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Tags:
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
earnings
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
antibody-drug conjugate
,
Enhertu
,
pan-tumor
,
FDA
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
Tags:
BioNTech
,
Duality Biologics
,
clinical trials
,
breast cancer
,
AstraZeneca
,
Daiichi Sankyo
,
HER2+ breast cancer
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News
Pharmaphorum
Wed, 01/17/24 - 09:38 am
Tags:
Seagen
,
Daiichi Sankyo
,
patents
,
legal
,
Enhertu
,
USPTO
FDA grants priority review for Daiichi Sankyo-Merck’s lung cancer therapy
Pharmaceutical Business Review
Wed, 12/27/23 - 11:00 pm
Tags:
Daiichi Sankyo
,
Merkc
,
patritumab deruxtecan
,
FDA
,
non-small cell lung cancer
Daiichi Sankyo unit claims $182m in Novartis patent dispute
Pharmaphorum
Wed, 12/6/23 - 10:31 am
Tags:
Daiichi Sankyo
,
Novartis
,
Plexxikon
,
legal
,
patents
,
Tafinlar
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Thu, 11/16/23 - 10:22 pm
Tags:
Japan
,
Daiichi Sankyo
,
COVID-19
,
vaccines
Daiichi-Sankyo ups revenue forecast thanks to massive Merck deal
Fierce Biotech
Tue, 10/31/23 - 09:30 pm
Tags:
Daiichi Sankyo
,
Merck
,
antibody-drug conjugate
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
Tags:
AbbVie
,
Daiichi Sankyo
,
Merck
,
antibody-drug conjugate
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
Tags:
ESMO
,
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
patient deaths
,
clinical trials
,
non-small cell lung cancer
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Tags:
Merck
,
Daiichi Sankyo
,
AstraZeneca
,
antibody-drug conjugate
Seagen wins future royalties in Enhertu patent dispute
Pharmaphorum
Wed, 10/18/23 - 10:07 am
Tags:
Seagen
,
Daiichi Sankyo
,
breast cancer
,
Enhertu
,
drug royalties
BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC
Fierce Biotech
Thu, 10/12/23 - 10:07 am
Tags:
BioNTech
,
Daiichi Sankyo
,
antibody-drug conjugate
,
breast cancer
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.